Apellis Pharmaceuticals (APLS) stock forecast for 2022 – 2027

Are you interested in Apellis Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the APLS stock price in 2022-2027. Is APLS a good long term stock? When should I take profit in Apellis Pharmaceuticals stock? Buy or sell stock? Will APLS stock price go up? What are analysts’ forecasts for APLS stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. APLS stock returns are also predicted based on historical data.

According to our research, APLS stock is a good long-term investment. APLS share price has been in a bull cycle for the past year. Apellis Pharmaceuticals, Inc. stock trend is positive.

Apellis Pharmaceuticals company info

Industry Biotechnology
Address 100 Fifth Avenue, Waltham, MA, 02451, United States
Website https://www.apellis.com

Forecasting

52 Week High: 49.0377 USD
52 Week Low: 39.05 USD
1 Year Forecast: 50.437 USD
5 Year Forecast: 92.1376 USD

Agilent Technologies info

Market Cap: 3.51B
52 Week Change: -5.819%
52 Week High: 73 USD
52 Week Low: 27.5 USD
Beta: 1.09518
50 Day Moving Average: 43.49
90 Day Moving Average: 42.467
200 Day Moving Average: 45.65
Resistance Level: 42.221
Pivot Point: 40.6337
Support Level: 38.263
Enterprise Value: 3,727,271,680
Forward P/E: -7.35
Forward EPS: -5.25
Profit Margin: -202.97%
Shares Outstanding: 97,357,904
EBITDA: -11.81
Held Percent Institutions: 73.89%
PEG Ratio (5Y): -0.16
Trailing EPS: -6.47

Apellis Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Apellis Pharmaceuticals Stock Forecast for 2022

March 2022 36 36.72 2%
April 2022 35.64 37.24 4.49%
May 2022 38.38 38.61 0.6%
June 2022 39.78 40.59 2.04%
July 2022 41.41 41 -0.99%
August 2022 40.59 40.18 -1.01%
September 2022 41.82 39 -6.74%
October 2022 40 39.6 -1%
November 2022 39.2 44.88 14.49%
December 2022 44 46.46 5.59%

Apellis Pharmaceuticals Stock Forecast for 2023

January 2023 46.46 45.08 -2.97%
February 2023 45.08 47.47 5.3%
March 2023 46.53 46.53 0%
April 2023 47.47 47.52 0.11%
May 2023 48.48 49.49 2.08%
June 2023 49 51.51 5.12%
July 2023 51 49.98 -2%
August 2023 49.98 51.48 3%
September 2023 52.52 51 -2.89%
October 2023 51 52.02 2%
November 2023 50.49 53.46 5.88%
December 2023 53.46 54.88 2.66%

Apellis Pharmaceuticals Stock Forecast for 2024

January 2024 56.56 55.86 -1.24%
February 2024 55.86 57 2.04%
March 2024 55.86 56.43 1.02%
April 2024 56.43 58.41 3.51%
May 2024 58.41 60 2.72%
June 2024 58.8 59.78 1.67%
July 2024 59.78 59.78 0%
August 2024 61 63.24 3.67%
September 2024 62 59.4 -4.19%
October 2024 61.2 61 -0.33%
November 2024 62.22 63.36 1.83%
December 2024 65.28 67.32 3.12%

Apellis Pharmaceuticals Stock Forecast for 2025

January 2025 65.34 66.33 1.52%
February 2025 67 65.66 -2%
March 2025 67.32 65.66 -2.47%
April 2025 66.33 68.31 2.99%
May 2025 69.69 70.7 1.45%
June 2025 68.6 71.28 3.91%
July 2025 71.28 70.56 -1.01%
August 2025 73.44 72.72 -0.98%
September 2025 73.44 68.6 -6.59%
October 2025 70.7 72.42 2.43%
November 2025 71.28 73.5 3.11%
December 2025 75.75 77.77 2.67%

Apellis Pharmaceuticals Stock Forecast for 2026

January 2026 76.23 75.46 -1.01%
February 2026 78.54 78.78 0.31%
March 2026 78.78 79.56 0.99%
April 2026 76.44 80.8 5.7%
May 2026 79 78.4 -0.76%
June 2026 80 80.36 0.45%
July 2026 82.82 82.82 0%
August 2026 82 83 1.22%
September 2026 84.66 81.81 -3.37%
October 2026 79.38 81.81 3.06%
November 2026 82 84.15 2.62%
December 2026 86.7 87 0.35%

Apellis Pharmaceuticals Stock Forecast for 2027

January 2027 86.13 85.26 -1.01%